DarioHealth Corp. Common Stock
$7.20
$0.21 (+3.00%)
$7.03Day Range$7.20
Key Statistics
Market Cap
$68.50M
Shares Outstanding
9.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Mar 8, 2013
Round Lot
100
Locale
US
Trading Data
Day Open
$7.03
Day High
$7.20
Day Low
$7.03
Volume
28.2K
VWAP
$7.21
Prev Close
$6.99
Transactions
--
Acc. Volume
--
About DarioHealth Corp. Common Stock
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 3841165 employees322 W 57TH ST. #33B, NEW YORK, NY, 10019972-4-770-6377IPO Mar 8, 2013US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001533998
- Composite FIGI
- BBG003V5P7K2
- Share Class FIGI
- BBG003V5PCZ5
- Ticker Root
- DRIO
- SIC Code
- 3841
About DarioHealth Corp. Common Stock (DRIO) Stock
DarioHealth Corp. Common Stock (DRIO) closed the 2026-09-18 session at $7.20, up 3.00% versus the previous close (+0.21). The stock opened at $7.03 and traded between $7.03 and $7.20 during that session. Session trading volume was 28K shares. The volume-weighted average price (VWAP) is $7.21.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
DarioHealth Corp. Common Stock has a market capitalization of $68.5 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. DRIO is listed on the XNAS exchange. The company employs approximately 165 people. DarioHealth Corp. Common Stock is headquartered in NEW YORK, NY. The recorded listing date is 2013-03-08.
On this page you can find market DRIO stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.